Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenli Dong

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Cancer Medicine|July 12, 2021
Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patientsChirayu Mohindroo, Merve Hasanov, Jane E Rogers, et al.
Endoscopic Ultrasound|July 1, 2024
New-onset diabetes is a predictive risk factor for pancreatic lesions in high-risk individuals: An observational cohort studySeyda Baydogan, Chirayu Mohindroo, Merve Hasanov, et al.
Journal of Cardiovascular Imaging|October 16, 2019
Coronary Artery Dose-Volume Parameters Predict Risk of Calcification After Radiation TherapySarah A Milgrom, Bibin Varghese, Gregory W Gladish, et al.
Leukemia & Lymphoma|May 10, 2017
Radiation therapy improves survival in patients with testicular diffuse large B-cell lymphoma<sup/>Jennifer C Ho, Bouthaina S Dabaja, Sarah A Milgrom, et al.
The Lancet. Haematology|June 6, 2024
Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trialJillian R Gunther, Jie Xu, Manoop S Bhutani, et al.
Nature Medicine|January 16, 2026
Nous-209 neoantigen vaccine for cancer prevention in Lynch syndrome carriers: a phase 1b/2 trialAnna Morena D'Alise, Jason Willis, Fahriye Duzagac, et al.
Cell|August 10, 2019
Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer OutcomesErick Riquelme, Yu Zhang, Liangliang Zhang, et al.
Lancet (London, England)|July 21, 2023
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trialJoe Y Chang, Steven H Lin, Wenli Dong, et al.
Blood Cancer Journal|May 9, 2025
Outcomes of elderly patients with relapsed refractory multiple myeloma (RRMM) treated with teclistamab: a multicenter study from the U.S. Multiple Myeloma Immunotherapy ConsortiumOren Pasvolsky, Danai Dima, Lei Feng, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Cancer Medicine|July 12, 2021
Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patientsChirayu Mohindroo, Merve Hasanov, Jane E Rogers, et al.
Endoscopic Ultrasound|July 1, 2024
New-onset diabetes is a predictive risk factor for pancreatic lesions in high-risk individuals: An observational cohort studySeyda Baydogan, Chirayu Mohindroo, Merve Hasanov, et al.
Journal of Cardiovascular Imaging|October 16, 2019
Coronary Artery Dose-Volume Parameters Predict Risk of Calcification After Radiation TherapySarah A Milgrom, Bibin Varghese, Gregory W Gladish, et al.
Leukemia & Lymphoma|May 10, 2017
Radiation therapy improves survival in patients with testicular diffuse large B-cell lymphoma<sup/>Jennifer C Ho, Bouthaina S Dabaja, Sarah A Milgrom, et al.
The Lancet. Haematology|June 6, 2024
Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trialJillian R Gunther, Jie Xu, Manoop S Bhutani, et al.
Nature Medicine|January 16, 2026
Nous-209 neoantigen vaccine for cancer prevention in Lynch syndrome carriers: a phase 1b/2 trialAnna Morena D'Alise, Jason Willis, Fahriye Duzagac, et al.
Cell|August 10, 2019
Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer OutcomesErick Riquelme, Yu Zhang, Liangliang Zhang, et al.
Lancet (London, England)|July 21, 2023
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trialJoe Y Chang, Steven H Lin, Wenli Dong, et al.
Blood Cancer Journal|May 9, 2025
Outcomes of elderly patients with relapsed refractory multiple myeloma (RRMM) treated with teclistamab: a multicenter study from the U.S. Multiple Myeloma Immunotherapy ConsortiumOren Pasvolsky, Danai Dima, Lei Feng, et al.
Pageof 8